StreetInsider.com News Articles

LIXTE Biotechnology raises $16.6 million through registered direct offering

Wed, 03 Jun 2026 08:30:29 -0400

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) completed a registered direct offering worth approximately $16.6 million through the sale of common stock and pre-funded warrants to accredited investors.

The company sold 2,625,362 shares of common stock and pre-funded warrants at $6.31 per share and $0.0001 per pre-funded warrant. Each pre-funded warrant entitles the holder to purchase one share of common stock and is immediately exercisable.

The offering was priced at market rates under Nasdaq rules and is expected to close on June 3, 2026, subject to customary closing conditions. LIXTE plans to use the net proceeds for general corporate purposes, working capital, and

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Wed, 03 Jun 2026 08:30:00 -0400

Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy and Infrastructure Investor — to the Company’s Board of Directors

BOCA RATON, FLA, June 03, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) (the “Company”), today announced that it has entered into definitive agreements in a registered direct offering with accredited investors for the purchase and sale of approximately $16,566,027 of shares of common stock and pre-funded warrants at an offering price of (i) $6.31 per share of common stock, and (ii) $0.0001 per pre-funded warrant. The entire

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Wed, 03 Jun 2026 08:30:00 -0400

Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy and Infrastructure Investor — to the Company’s Board of Directors

Form 4 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D

Mon, 01 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260601/26583317.html

Form 4 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D

Mon, 01 Jun 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260601/26583317.html

Form 3 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583284.html

Form 3 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583284.html

Form 8-K LIXTE BIOTECHNOLOGY HOLD For: May 29

Mon, 01 Jun 2026 08:55:00 -0400

si-local-file:///var/storage/secattach/20260601/26580125.html

Form 8-K LIXTE BIOTECHNOLOGY HOLD For: May 29

Mon, 01 Jun 2026 08:55:00 -0400

si-local-file:///var/storage/secattach/20260601/26580125.html

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company said it will focus on meeting power demands of AI and hyperscale data centers.

Stuart D. Porter, founder and managing partner of Denham Capital Management LP, joined LIXTE's board of directors. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure services

Mon, 01 Jun 2026 08:50:34 -0400

The company cited North American Electric Reliability Corporation data projecting summer peak demand will increase by 224 gigawatts over the next decade. NERC issued

LIXTE Biotechnology pivots to AI energy infrastructure business

Mon, 01 Jun 2026 08:50:16 -0400

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) announced a strategic transformation from a clinical-stage pharmaceutical company to an AI energy infrastructure equipment and services platform. The company cited growing power demands from AI and hyperscale data centers as the driver for the business pivot.

Stuart D. Porter, founder of Denham Capital Management LP, joined LIXTE's board of directors effective June 1, 2026. Porter has overseen more than $12 billion of invested and committed capital across energy sectors since founding Denham Capital in 2004.

The transformation follows projections from the North American Electric Reliability Corporation that summer peak demand will increase by 224 gigawatts

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors